Key Management

Torsten Goesch
MD, PhD, MBA

Director of Rosetta Capital. Former positions include General Manager, Biogen & Commercial Head, Merck Genetics

Torsten

Founder & Chairman

Ningfeng Fiona Li
MD, PhD, MSc

Specialised in clinical radiation oncology, with extensive scientific experience in tumour research and genetics. Founder of London Nanjing Life Science (China) Ltd. and Suzhou NG Biomedicine Ltd.

Fiona

CEO & Founder

Andrew Mackie
BSc, LLB, MBA

R&D and Commercial roles at Novartis, Sanofi and Eli Lilly; Chief Business Officer, Ergomed and Head of Life Sciences at IP Group.

Andrew

Director & CBO

Gary Bower
BSc

Specialist in managing clinical trials with 20 + years experience. Founder of GTE Consultancy Ltd supporting small biotechnology companies with clinical and pre-clinical development since 2006.

Gary

COO

Christian Girard
MiM

Founder of Orphan Drugs Industry Advisory and Intelligence (France) a strategic advisory firm with a focus on value creation in the Orphan Drug area.

Christian

Senior Adviser, Regulatory Strategy

William (Bill) Fahl
PhD

Professor of Oncology, Wisconsin Ins. of Medical Research. Inventor of the NG11, NG12 and NG13 technology platform.

Bill

Senior Scientific Adviser